Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,982,116 papers from all fields of science
Search
Sign In
Create Free Account
Butaclamol Hydrochloride
Known as:
Hydrochloride, Butaclamol
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
AY-23,028
Butaclamol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Pharmacological Analysis of Human D1 and D2 Dopamine Receptor Missense Variants
M. Al-Fulaij
,
Yong Ren
,
M. Beinborn
,
A. Kopin
Journal of Molecular Neuroscience
2008
Corpus ID: 11503320
Drugs targeting dopamine receptors have been the focus of much research over the past 30 years, in large part because of their…
Expand
1995
1995
[3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
S. Gackenheimer
,
J. Schaus
,
D. Gehlert
Journal of Pharmacology and Experimental…
1995
Corpus ID: 22137798
Quinelorane is a BCD partial ergoline with potent dopaminergic effects in vitro and in vivo. Partial ergoline compounds of this…
Expand
1993
1993
Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: Identification of a discrete population of putative D3 receptors
B. Levant
,
E. D. De Souza
Synapse
1993
Corpus ID: 12960011
We have previously identified [3H]quinpirole‐labeled dopamine receptors in the molecular layer of cerebellar lobule 10 which have…
Expand
Highly Cited
1989
Highly Cited
1989
3-(2'-[18F]Fluoroethyl)Spiperone: In vivo Biochemical and Kinetic Characterization in Rodents, Nonhuman Primates, and Humans
J. Barrio
,
N. Satyamurthy
,
+7 authors
M. Phelps
Journal of Cerebral Blood Flow and Metabolism
1989
Corpus ID: 39398497
3-(2'-[18F]fluoroethyl)spiperone (FESP), a recently developed dopamine D2-receptor binding radiopharmaceutical, was used for…
Expand
Highly Cited
1989
Highly Cited
1989
Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
C. Saller
,
Lori D. Kreamer
,
Lisa A. Adamovage
,
A. Salama
Life Science
1989
Corpus ID: 23870017
Highly Cited
1988
Highly Cited
1988
Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist Bay-K-8644 through a pertussis toxin-sensitive G protein in anterior pituitary cells.
A. Enjalbert
,
F. Musset
,
C. Chenard
,
M. Priam
,
C. Kordon
,
S. Heisler
Endocrinology
1988
Corpus ID: 7293516
In primary culture of anterior pituitary cells, BAY-K-8644, a calcium channel agonist, stimulated PRL secretion by 83% with EC50…
Expand
Highly Cited
1981
Highly Cited
1981
Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.
Christer Köhler
,
Christer Köhler
,
Kjell Fuxe
,
Kjell Fuxe
,
S. B. Ross
,
S. B. Ross
European Journal of Pharmacology
1981
Corpus ID: 4525020
1980
1980
Role of central nervous system neurotransmitters in mediating the effects of morphine on growth hormone-and prolactin-secretion in the rat
J. Koenig
,
M. A. Mayfield
,
R. J. Coppings
,
S. Mccann
,
L. Krulich
Brain Research
1980
Corpus ID: 1372000
Highly Cited
1976
Highly Cited
1976
Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors
J. R. Walters
,
R. Roth
Naunyn-Schmiedeberg's Archives of Pharmacology
1976
Corpus ID: 22266663
SummaryAn in vivo system has been used to investigate the ability of dopamine agonists and antagonists to alter dopamine…
Expand
1975
1975
Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds.
Bruderlein Ft
,
Humber Lg
1975
Corpus ID: 198269316
: The syntheses and the structural and stereochemical requirements for antagonism of (+)-amphetamine-induced sterotypy are…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required